References
- Addo RT, Siddig A, Siwale R, Patel NJ, Akande J, Uddin AN, D’Souza MJ. Formulation, characterization and testing of tetracaine hydrochloride-loaded albumin-chitosan microparticles for ocular drug delivery. J Microencapsul, 2010;27(2):95–104.
- Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J. Leishmaniasis worldwide and global estimates of its incidence. PLoS One, 2012;7(5):e35671.
- Baker RW. 1987. Controlled release of biologically active agents. New York: John Wiley & Sons.
- Batycky RP, Hanes J, Langer R, Edwards DA. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci, 1997;86(12):1464–77.
- Bediako A, Adotey J, Ofori-Kwakye K. Pharmacokinetics of amodiaquine after a single oral dose in Ghanaian children with uncomplicated malaria. J Pharm Sci Res 2011;3(8):1423.
- Brazel C, Peppas N. Recent studies and molecular analysis of drug release from swelling-controlled devices. STP Pharma Sci, 1999;9(5):473–85.
- Elfarra A. (2009). Advances in bioactivation research. New York: Springer.
- Giao PT, de Vries PJ. Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet, 2001;40(5):343–73.
- Gitau E, Muchohi S, Ogutu B, Githiga I, Kokwaro G. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. J Chromatogr B, 2004;799(1):173–7.
- Grassi M, Grassi G, Lapasin R, Colombo I. 2006. Understanding drug release and absorption mechanisms: a physical and mathematical approach. Boca Raton: CRC Press.
- Haswani DK, Nettey H, Oettinger C, D'souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microsperes. J Microencapsul, 2006;23:875–86.
- Jalil R, Nixon J. Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul, 1990;7(3):297–325.
- Kim KK, Pack DW. Microspheres for drug delivery. Bio-MEMS Biomed Nanotechnol, 2006;1:21.
- Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharm, 1996;30(4):263–99.
- Le Fur N, Hochart G, Larchanche PE, Melnyk P. Buchwald reaction as the key step for the synthesis of metabolically more stable analogs of amodiaquine. Eur J Med Chem, 2011;46(7):3052–7.
- Lee AP, Lee LJ. (2006). BioMEMS and Biomedical Nanotechnology: biological and biomedical nanotechnology. Vol. 1. New York: Springer; pp. 19.
- Liggins RT, Burt HM. Paclitaxel loaded poly (L-lactic acid)(PLLA) microspheres: II. The effect of processing parameters on microsphere morphology and drug release kinetics. Int J Pharm, 2004;281(1):103–6.
- Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis, 1999;180(2):564–7.
- Mallapragada SK, Peppas NA, Colombo P. Crystal dissolution-controlled release systems. II. Metronidazole release from semicrystalline poly (vinyl alcohol) systems. J Biomed Mater Res, 1997;36(1):125–30.
- Murray HW. Advances in leishmaniasis. Lancet (London, UK). 2005;366(9496):1561–77.
- Nettey H, Allotey-Babington GL, Nguessan BB, Afrane B, Tagoe M, Ababio A, Botchway P, Darko Y, Sasu C, Nyarko A. Screening of anti-infectives against Leishmania donovani. Adv Microbiol, 2016;6(01):13.
- Omkar T, Alagusundaram M, Madhu S, Umashankari K, Attuluri V, Lavanya C, Ramkanth B. Microspheres as a novel drug delivery system. Int J Chem Tech Res, 2009;3(1):526–34.
- Park TG, Cohen S, Langer R. Controlled protein release from polyethyleneimine-coated poly (L-lactic acid)/pluronic blend matrices. Pharm Res, 1992;9(1):37–9.
- Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol, 2014;6:147–54.
- Rowe P. 2012. Pharmacokinetics. Philip Rowe & Ventus Publishing ApS: Bookboon.
- Sharma S, Khuller G, Garg S. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects. J Antimicrob Chemother, 2003;51(4):931–8.
- Varde NK. 2007. Elucidation of drug release mechanisms in PLGA microspheres. [Dissertation.] Urbana, Illinois: ProQuest Information & Learning Company.
- Volpe DA, Hamed SS, Zhang LK. Use of different parameters and equations for calculation of IC50 values in efflux assays: potential sources of variability in IC50 determination. AAPS J, 2014;16(1):172–80.
- Vyas SP, Khar RK. 2007. Targeted & controlled drug delivery: novel carrier systems. New Delhi: CBS Publishers & Distributors.
- White NJ, Looareesuwan S, Edwards G, Phillips RE, Karbwang J, Nicholl DD, Bunch C, Warrell DA. Pharmacokinetics of intravenous amodiaquine. Br J Clin Pharm, 1987;23(2):127–35.
- Winstanley P, Edwards G, Curtis C, Orme ME, Powell G, Breckenridge A. Tissue distribution and excretion of amodiaquine in the rat. J Pharm Pharmacol, 1988;40(5):343–9.
- Winstanley P, Rodick C, Edwards G, ORME M, Breckenridge A. The disposition of amodiaquine in man after a single oral dose. Br J Clin Pharmacol, 1986;23:1–7.
- Wise DL. 2000. Handbook of pharmaceutical controlled release technology. New York: Taylor & Francis.